<DOC>
	<DOC>NCT00229112</DOC>
	<brief_summary>This study will compare the efficacy, safety and tolerability of intravenous ertapenem versus another intravenous antibiotic in the treatment of moderate to severe diabetic foot infections.</brief_summary>
	<brief_title>Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Focal Infection</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Piperacillin, tazobactam drug combination</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<criteria>Type 1 or 2 Diabetes Mellitus treated with diet or medication Clinically or microbiologically documented foot infection below the knee Osteomyelitic bone must be removed within 48 hours of study entry Uncomplicated skin infections Infected burn wounds Necrotizing fascitis Wounds with gangrene that cannot be removed with debridement Infections of prosthetic materials Foreign materials that can not be removed by surgical debridement Patients with another antibiotic 3 days prior to enrollment without evidence of treatment failure and presence of a positive culture Insufficient blood flow to the limb requiring a revascularization procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>